Be part of the knowledge.™

Oncology and Hematology

9

LikeLikedUnlike

1-15 of 25

Rewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
Medical Industry Feature
Rewiring Your Thinking in Paroxysmal Nocturnal Hemoglobinuria
- Steve Stone, PA-C
  Peer
- George Yaghmour, MD
  Peer
Moving Beyond Hesitation: Exploring an Oral Option for Managing PNH
Medical Industry Feature
Moving Beyond Hesitation: Exploring an Oral Option for Managing PNH
- Steve Stone, PA-C
  Peer
- Jamile Shammo, MD, FASCP, FACP
  Peer
Personalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
Medical Industry Feature
Personalizing PNH Care: Exploring the Role of Iptacopan in Clinical Practice
- Steve Stone, PA-C
  Peer
- Srinivasa Sanikommu, MD
  Peer
Bridging the Gap in AYA Cure Rates
Medical Industry Feature
Bridging the Gap in AYA Cure Rates
- Ibrahim Aldoss, MD
  Peer
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jaffer Ajani, MD
  Peer
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
Medical Industry Feature
Latest TROP2 ADC Approval for HR+ HER2- Metastatic Breast Cancer
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Komal Jhaveri, MD, FACP
  Peer
- Vanessa Soto-Romano
  Peer
advertisement
Managing Eye-Related Adverse Events Caused by Cancer Treatments
Medical Industry Feature
Managing Eye-Related Adverse Events Caused by Cancer Treatments
- Neel D. Pasricha, MD
  Peer
MIRASOL Insights in PROC: A Biomarker-Driven Approach
Project Oncology®
MIRASOL Insights in PROC: A Biomarker-Driven Approach
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Cecelia Boardman, MD
  Peer
Operational Considerations for Bispecific T-Cell Engager Therapies
Medical Industry Feature
Operational Considerations for Bispecific T-Cell Engager Therapies
- Jennifer Caudle, DO, FACOFP
  Peer
- David M. Waterhouse, MD, MPH
  Peer
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
Medical Industry Feature
New Trial Device Opens Blood-Brain Barrier to Treat Glioblastoma
- Brian Gill, M.D.
  Peer
Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
Project Oncology®
Investigator Perspectives on Treating Patients in a Ph2 NSCLC Trial
- Jennifer Caudle, DO, FACOFP
  Peer
- D. Ross Camidge, MD, PhD
  Peer
- Jonathan Goldman, MD
  Peer
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry Feature
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
- Joel Gabre, M.D, MPH
  Peer
advertisement
Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
Medical Industry Feature
Managing Capillary Leak Syndrome: Early Recognition and Intervention in BPDCN Care
- Jennifer Caudle, DO, FACOFP
  Peer
- James McCloskey II, MD
  Peer
Advancing Care in Pretreated HR+/HER2- mBC
Medical Industry Feature
Advancing Care in Pretreated HR+/HER2- mBC
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Aashini Master, DO
  Peer
- Neil M. Iyengar, MD
  Peer
Supportive Care in Patients with Pretreated HR+/HER2- mBC
Medical Industry Feature
Supportive Care in Patients with Pretreated HR+/HER2- mBC
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Aashini Master, DO
  Peer
- Neil M. Iyengar, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended